Norges Bank Phathom Pharmaceuticals, Inc. Transaction History

Norges Bank

$736 Billion
Q4 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2023	BUY	$11.55 - $20.06 $7.63 Million - $13.3 Million	660,690 New	660,690 $8.99 Million
Q1 2022 May 09, 2022	SELL	$11.55 - $20.06 $7.63 Million - $13.3 Million	-660,690 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$17.83 - $33.15 $11.8 Million - $21.9 Million	660,690 New	660,690 $13 Million
Q3 2021 Nov 14, 2022	BUY	$30.69 - $36.83 $10.1 Million - $12.1 Million	329,343 New	329,343 $10.6 Million
Q3 2021 Nov 05, 2021	SELL	$30.69 - $36.83 $10.1 Million - $12.1 Million	-329,343 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$32.66 - $39.87 $10.8 Million - $13.1 Million	329,343 New	329,343 $11.1 Million
Q2 2021 Aug 10, 2021	SELL	$32.66 - $39.87 $10.8 Million - $13.1 Million	-329,343 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$33.86 - $48.68 $11.2 Million - $16 Million	329,343 New	329,343 $12.4 Million
Q1 2021 May 07, 2021	SELL	$33.86 - $48.68 $11.2 Million - $16 Million	-329,343 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$33.22 - $50.26 $10.9 Million - $16.6 Million	329,343 New	329,343 $10.9 Million
Q4 2020 Feb 10, 2021	SELL	$33.22 - $50.26 $8.62 Million - $13 Million	-259,343 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$29.24 - $40.19 $7.58 Million - $10.4 Million	259,343 New	259,343 $9.51 Million
Q3 2020 Nov 10, 2020	SELL	$29.24 - $40.19 $7.58 Million - $10.4 Million	-259,343 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$25.06 - $54.6 $6.5 Million - $14.2 Million	259,343 New	259,343 $8.54 Million
Q2 2020 Aug 07, 2020	SELL	$25.06 - $54.6 $6.5 Million - $14.2 Million	-259,343 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$24.65 - $42.83 $6.39 Million - $11.1 Million	259,343 New	259,343 $6.7 Million
Q1 2020 May 08, 2020	SELL	$24.65 - $42.83 $7.82 Million - $13.6 Million	-317,300 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$18.59 - $37.67 $5.9 Million - $12 Million	317,300 New	317,300 $9.88 Million

Others Institutions Holding PHAT

# of Institutions

158

Shares Held

68.6M

Call Options Held

52.3K

Put Options Held

635K

Frazier Life Sciences Management, L.P. Menlo Park, CA

10.1M
Shares

$61.5 Million
4.92% of portfolio
Medicxi Ventures Management (Jersey) LTD

7.46M
Shares

$45.4 Million
13.31% of portfolio
Jennison Associates LLC

7.06M
Shares

$42.9 Million
0.04% of portfolio
Invesco Ltd. Atlanta, GA

3.67M
Shares

$22.3 Million
0.01% of portfolio
Carlyle Group Inc. Washington, DC

3.5M
Shares

$21.3 Million
28.4% of portfolio

View Full List

About Phathom Pharmaceuticals, Inc.

Ticker PHAT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,175,200
Market Cap $238M
Description
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...

More about PHAT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account